Literature DB >> 23834475

Degradation of MSCRAMM target macromolecules in VLU slough by Lucilia sericata chymotrypsin 1 (ISP) persists in the presence of tissue gelatinase activity.

David I Pritchard1, Alan P Brown1.   

Abstract

Venous leg ulcer slough is unpleasant to the patient and difficult to manage clinically. It harbours infection, also preventing wound management materials and dressings from supporting the underlying viable tissues. In other words, slough has significant nuisance value in the tissue viability clinic. In this study, we have sought to increase our knowledge of slough by building upon a previous but limited analysis of this necrotic tissue. In particular, slough has been probed using Western blotting for the presence of proteins with the capacity to engage microbial surface components recognising adhesive matrix macromolecules. Although the samples were difficult to resolve, we detected fibrinogen, fibronectin, IgG, collagen, human serum albumin and matrix metalloproteinase-9. Furthermore, the effect of a maggot-derived debridement enzyme, chymotrypsin 1 on macromolecules in slough was confirmed across seven patient samples. The effect of chymotrypsin 1 on slough confirms our thesis that this potential debridement enzyme could be effective in removing slough along with its associated bacteria, given its observed resistance to intrinsic gelatinase activity. In summary, we believe that the data provide scientists and clinicians with further insights into the potential molecular interactions between bacteria, wound tissue and Lucilia sericata in a clinically problematic yet scientifically interesting wound ecosystem.
© 2013 The Authors. International Wound Journal © 2013 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Bacterial adhesins; Insect serine proteinase; Matrix metalloproteinase; Venous leg ulcer

Mesh:

Substances:

Year:  2013        PMID: 23834475      PMCID: PMC7950951          DOI: 10.1111/iwj.12124

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  56 in total

Review 1.  Structure and function of matrix metalloproteinases and TIMPs.

Authors:  Hideaki Nagase; Robert Visse; Gillian Murphy
Journal:  Cardiovasc Res       Date:  2006-01-05       Impact factor: 10.787

Review 2.  The burden of chronic wounds in the UK.

Authors:  John Posnett; Peter J Franks
Journal:  Nurs Times       Date:  2008 Jan 22-28

Review 3.  Evolving concepts in biofilm infections.

Authors:  Luanne Hall-Stoodley; Paul Stoodley
Journal:  Cell Microbiol       Date:  2009-04-06       Impact factor: 3.715

4.  Galectin-3-mediated adherence of Proteus mirabilis to Madin-Darby canine kidney cells.

Authors:  E Altman; B A Harrison; R K Latta; K K Lee; J F Kelly; P Thibault
Journal:  Biochem Cell Biol       Date:  2001       Impact factor: 3.626

5.  Aggregation substance-mediated adherence of Enterococcus faecalis to immobilized extracellular matrix proteins.

Authors:  E Rozdzinski; R Marre; M Susa; R Wirth; A Muscholl-Silberhorn
Journal:  Microb Pathog       Date:  2001-04       Impact factor: 3.738

6.  Identification of a fibronectin-binding protein from Staphylococcus epidermidis.

Authors:  Rachel J Williams; Brian Henderson; Lindsay J Sharp; Sean P Nair
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Maggot excretions/secretions are differentially effective against biofilms of Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Mariena J A van der Plas; Gerrolt N Jukema; Sin-Wen Wai; Heleen C M Dogterom-Ballering; Ellen L Lagendijk; Co van Gulpen; Jaap T van Dissel; Guido V Bloemberg; Peter H Nibbering
Journal:  J Antimicrob Chemother       Date:  2007-10-26       Impact factor: 5.790

8.  Inhibition of Pseudomonas aeruginosa adhesion to fibronectin by PA-IL and monosaccharides: involvement of a lectin-like process.

Authors:  Julie Rebiere-Huët; Patrick Di Martino; Christian Hulen
Journal:  Can J Microbiol       Date:  2004-05       Impact factor: 2.419

9.  Expression of a cGMP compatible Lucilia sericata insect serine proteinase debridement enzyme.

Authors:  David I Pritchard; Gary Telford; Miliza Diab; Walter Low
Journal:  Biotechnol Prog       Date:  2012-02-17

10.  Larval therapy for leg ulcers (VenUS II): randomised controlled trial.

Authors:  Jo C Dumville; Gill Worthy; J Martin Bland; Nicky Cullum; Christopher Dowson; Cynthia Iglesias; Joanne L Mitchell; E Andrea Nelson; Marta O Soares; David J Torgerson
Journal:  BMJ       Date:  2009-03-19
View more
  5 in total

Review 1.  TIME management by medicinal larvae.

Authors:  David I Pritchard; Václav Čeřovský; Yamni Nigam; Samantha F Pickles; Gwendolyn Cazander; Peter H Nibbering; Anke Bültemann; Wilhelm Jung
Journal:  Int Wound J       Date:  2015-07-15       Impact factor: 3.315

Review 2.  Parasite-bacteria interrelationship.

Authors:  Dalia S Ashour; Ahmad A Othman
Journal:  Parasitol Res       Date:  2020-08-04       Impact factor: 2.289

Review 3.  Pharmacological Properties of the Medical Maggot: A Novel Therapy Overview.

Authors:  Litao Yan; Jin Chu; Mingshu Li; Xianfeng Wang; Junwei Zong; Xueyang Zhang; Mingzhi Song; Shouyu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2018-05-03       Impact factor: 2.629

Review 4.  Practical context of enzymatic treatment for wound healing: A secreted protease approach (Review).

Authors:  María Isabela Avila-Rodríguez; David Meléndez-Martínez; Cuauhtemoc Licona-Cassani; José Manuel Aguilar-Yañez; Jorge Benavides; Mirna Lorena Sánchez
Journal:  Biomed Rep       Date:  2020-04-27

5.  Next Generation Sequencing Identifies Five Major Classes of Potentially Therapeutic Enzymes Secreted by Lucilia sericata Medical Maggots.

Authors:  Zdeněk Franta; Heiko Vogel; Rüdiger Lehmann; Oliver Rupp; Alexander Goesmann; Andreas Vilcinskas
Journal:  Biomed Res Int       Date:  2016-03-28       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.